Transactions

Gryphon Investors acquired Synteract

Client: Synteract is a mid-sized Contract Research Organization (CRO) focused on central nervous system (CNS) and Oncology Trials

Role: Edgemont Partners acted as exclusive financial advisor to Gryphon Investors in its acquisition of Synteract from Celerity Partners

Location: Carlsbad, CA

Sector: Pharmaceutical Services

Lead Banker: David Blume